Chemokines and Chemokine Receptors in Lymphoid Tissue Dynamics

Annual Review of Immunology

Volumn 34, Issue , 2016, Pages 203-242

  Schulz, Olga ^a   Hammerschmidt, Swantje I ^a   Moschovakis, G Leandros ^a   Förster, Reinhold ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cell migration; Lymph node; Lymphoid organ development; Lymphoid organ function; Spleen; Thymus

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR;

CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELL SELECTION; DENDRITIC CELL; EFFECTOR CELL; EPITHELIUM CELL; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATORY CELL; LYMPHOID ORGAN; LYMPHOID TISSUE; NONHUMAN; PEYER PATCH; PRIMORDIUM; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; THYMUS; ANIMAL; CELL COMMUNICATION; CELL MOTION; IMMUNE SYSTEM; IMMUNOLOGY; INFECTION; INFLAMMATION; LYMPHOCYTE; LYMPHOCYTE ACTIVATION;

ANIMALS; CELL COMMUNICATION; CELL MOVEMENT; CHEMOKINES; HUMANS; IMMUNE SYSTEM; INFECTION; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; LYMPHOID TISSUE; RECEPTORS, CHEMOKINE;

EID: 84969850531     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-041015-055649     Document Type: Review

References (246)

1. van Pavert SA, Mebius RE. 2010. New insights into the development of lymphoid tissues. Nat. Rev. Immunol. 10:664-74
2. Kufareva I, Salanga CL, Handel TM. 2015. Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies. Immunol. Cell Biol. 93:372-83
3. Zlotnik A, Yoshie O. 2012. The chemokine superfamily revisited. Immunity 36:705-16
4. Flad HD, Brandt E. 2010. Platelet-derived chemokines: pathophysiology and therapeutic aspects. Cell Mol. Life Sci. 67:2363-86
5. Nomiyama H, Osada N, Yoshie O. 2010. The evolution of mammalian chemokine genes. Cytokine Growth Factor Rev. 21:253-62
6. Bachelerie F, Ben-Baruch A, Burkhardt AM, Combadiere C, Farber JM, et al. 2014. InternationalUnion of Pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol. Rev. 66:1-79
7. Lefkowitz RJ, Shenoy SK. 2005. Transduction of receptor signals by β-arrestins. Science 308:512-17
8. Nibbs RJ, Graham GJ. 2013. Immune regulation by atypical chemokine receptors. Nat. Rev. Immunol. 13:815-29
9. Bachelerie F, Graham GJ, Locati M, Mantovani A, Murphy PM, et al. 2014. New nomenclature for atypical chemokine receptors. Nat. Immunol. 15:207-8
10. Girard JP, Moussion C, Forster R. 2012. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat. Rev. Immunol. 12:762-73
11. Schumann K, Lammermann T, BrucknerM, Legler DF, Polleux J, et al. 2010. Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells. Immunity 32:703-13
12. Klein L, KyewskiB,AllenPM,Hogquist KA. 2014. Positive and negative selection of theTcell repertoire: what thymocytes see (and don't see). Nat. Rev. Immunol. 14:377-91
13. Blackburn CC, Manley NR. 2004. Developing a new paradigm for thymus organogenesis. Nat. Rev. Immunol. 4:278-89
14. Douagi I, Vieira P, Cumano A. 2002. Lymphocyte commitment during embryonic development, in the mouse. Semin. Immunol. 14:361-69
15. GunnMD,Kyuwa S,TamC, KakiuchiT,Matsuzawa A, et al. 1999. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189:451-60
16. Liu C, Ueno T, Kuse S, Saito F, Nitta T, et al. 2005. The role of CCL21 in recruitment of T-precursor cells to fetal thymi. Blood 105:31-39
17. Bleul CC, Boehm T. 2000. Chemokines define distinct microenvironments in the developing thymus. Eur. J. Immunol. 30:3371-79
18. Liu C, Saito F, Liu Z, Lei Y, Uehara S, et al. 2006. Coordination between CCR7-and CCR9-mediated chemokine signals in prevascular fetal thymus colonization. Blood 108:2531-39
19. Janas ML, Varano G, Gudmundsson K, Noda M, Nagasawa T, Turner M. 2010. Thymic development beyond β-selection requires phosphatidylinositol 3-kinase activation by CXCR4. J. Exp. Med. 207:247-61
20. Plotkin J, Prockop SE, Lepique A, Petrie HT. 2003. Critical role for CXCR4 signaling in progenitor localization and T cell differentiation in the postnatal thymus. J. Immunol. 171:4521-27
21. Calderon L, Boehm T. 2011. Three chemokine receptors cooperatively regulate homing of hematopoietic progenitors to the embryonic mouse thymus. PNAS 108:7517-22
22. Jenkinson WE, Rossi SW, Parnell SM, Agace WW, Takahama Y, et al. 2007. Chemokine receptor expression defines heterogeneity in the earliest thymic migrants. Eur. J. Immunol. 37:2090-96
23. Schwarz BA, Sambandam A, Maillard I, Harman BC, Love PE, Bhandoola A. 2007. Selective thymus settling regulated by cytokine and chemokine receptors. J. Immunol. 178:2008-17
24. Svensson M, Marsal J, Uronen-Hansson H, Cheng M, JenkinsonW, et al. 2008. Involvement of CCR9 at multiple stages of adult T lymphopoiesis. J. Leukoc. Biol. 83:156-64
25. Krueger A, Willenzon S, Lyszkiewicz M, Kremmer E, Forster R. 2010. CC chemokine receptor 7 and 9 double-deficient hematopoietic progenitors are severely impaired in seeding the adult thymus. Blood 115:1906-12
26. Trampont PC, Tosello-Trampont AC, Shen Y, Duley AK, Sutherland AE, et al. 2010. CXCR4 acts as a costimulator during thymic β-selection. Nat. Immunol. 11:162-70
27. Zlotoff DA, Sambandam A, Logan TD, Bell JJ, Schwarz BA, Bhandoola A. 2010. CCR7 and CCR9 together recruit hematopoietic progenitors to the adult thymus. Blood 115:1897-905
28. Lind EF, Prockop SE, Porritt HE, PetrieHT. 2001. Mapping precursormovement through the postnatal thymus reveals specific microenvironments supporting defined stages of early lymphoid development. J. Exp. Med. 194:127-34
29. Misslitz A, Bernhardt G, Forster R. 2006. Trafficking on serpentines: molecular insight on how maturating T cells find their winding paths in the thymus. Immunol. Rev. 209:115-28
30. Misslitz A, Pabst O, Hintzen G, Ohl L, Kremmer E, et al. 2004. Thymic T cell development and progenitor localization depend on CCR7. J. Exp. Med. 200:481-91
31. Benz C, Heinzel K, Bleul CC. 2004. Homing of immature thymocytes to the subcapsular microenvironment within the thymus is not an absolute requirement for T cell development. Eur. J. Immunol. 34:3652-63
32. Ueno T, Saito F, Gray DH, Kuse S, Hieshima K, et al. 2004. CCR7 signals are essential for cortexmedulla migration of developing thymocytes. J. Exp. Med. 200:493-505
33. Davalos-Misslitz AC, Rieckenberg J, Willenzon S, Worbs T, Kremmer E, et al. 2007. Generalized multi-organ autoimmunity in CCR7-deficient mice. Eur. J. Immunol. 37:613-22
34. Kurobe H, Liu C, Ueno T, Saito F, Ohigashi I, et al. 2006. CCR7-dependent cortex-to-medulla migration of positively selected thymocytes is essential for establishing central tolerance. Immunity 24:165-77
35. Ehrlich LI, Oh DY, Weissman IL, Lewis RS. 2009. Differential contribution of chemotaxis and substrate restriction to segregation of immature and mature thymocytes. Immunity 31:986-98
36. Davalos-Misslitz AC, Worbs T, Willenzon S, Bernhardt G, Forster R. 2007. Impaired responsiveness to T-cell receptor stimulation and defective negative selection of thymocytes in CCR7-deficient mice. Blood 110:4351-59
37. HuZ, Lancaster JN, SasipongananC,Ehrlich LI. 2015.CCR4promotesmedullary entry and thymocytedendritic cell interactions required for central tolerance. J. Exp. Med. 212:1947-65
38. Lucas B, White AJ, Ulvmar MH, Nibbs RJ, Sitnik KM, et al. 2015. CCRL1/ACKR4 is expressed in key thymic microenvironments but is dispensable for T lymphopoiesis at steady state in adult mice. Eur. J. Immunol. 45:574-83
39. HeinzelK, BenzC, Bleul CC. 2007. A silent chemokine receptor regulates steady-state leukocyte homing in vivo. PNAS 104:8421-26
40. Bunting MD, Comerford I, Seach N, Hammett MV, Asquith DL, et al. 2013. CCX-CKR deficiency alters thymic stroma impairing thymocyte development and promoting autoimmunity. Blood 121:118-28
41. Reinhardt A, Ravens S, Fleige H, Haas JD, Oberdorfer L, et al. 2014. CCR7-mediated migration in the thymus controls γ T-cell development. Eur. J. Immunol. 44:1320-29
42. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, et al. 2010. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466:829-34
43. Aiuti A,Webb IJ, Bleul C, Springer T,Gutierrez-Ramos JC. 1997. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J. Exp. Med. 185:111-20
44. Sugiyama T, Kohara H, Noda M, Nagasawa T. 2006. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25:977-88
45. Christopher MJ, Rao M, Liu F, Woloszynek JR, Link DC. 2011. Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J. Exp. Med. 208:251-60
46. DiPersio JF, Stadtmauer EA, Nademanee A, Micallef IN, Stiff PJ, et al. 2009. Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma. Blood 113:5720-26
47. Griffith JW, Sokol CL, Luster AD. 2014. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu. Rev. Immunol. 32:659-702
48. Randall TD, Carragher DM, Rangel-Moreno J. 2008. Development of secondary lymphoid organs. Annu. Rev. Immunol. 26:627-50
49. van Pavert SA, Mebius RE. 2014. Development of secondary lymphoid organs in relation to lymphatic vasculature. Adv. Anat. Embryol. Cell Biol. 214:81-91
50. Onder L, Danuser R, Scandella E, Firner S, Chai Q, et al. 2013. Endothelial cell-specific lymphotoxin-β receptor signaling is critical for lymph node and high endothelial venule formation. J. Exp. Med. 210:465-73
51. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:1037-47
52. AnselKM, NgoVN, Hyman PL, Luther SA, Forster R, et al. 2000.Achemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406:309-14
53. GunnMD,NgoVN,AnselKM,EklandEH, Cyster JG, WilliamsLT. 1998.AB-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391:799-803
54. Victora GD, Nussenzweig MC. 2012. Germinal centers. Annu. Rev. Immunol. 30:429-57
55. Forster R, Pabst O, Bernhardt G. 2008. Homeostatic chemokines in development, plasticity, and functional organization of the intestinal immune system. Semin. Immunol. 20:171-80
56. Brown FD, Turley SJ. 2015. Fibroblastic reticular cells: organization and regulation of theTlymphocyte life cycle. J. Immunol. 194:1389-94
57. Malhotra D, Fletcher AL, Astarita J, Lukacs-Kornek V, Tayalia P, et al. 2012. Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat. Immunol. 13:499-510
58. Tomei AA, Siegert S, Britschgi MR, Luther SA, Swartz MA. 2009. Fluid flow regulates stromal cell organization and CCL21 expression in a tissue-engineered lymph node microenvironment. J. Immunol. 183:4273-83
59. WendlandM,Willenzon S, Kocks J,Davalos-Misslitz AC, Hammerschmidt SI, et al. 2011. Lymph node T cell homeostasis relies on steady state homing of dendritic cells. Immunity 35:945-57
60. LeyK,Laudanna C, CybulskyMI, Nourshargh S. 2007. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7:678-89
61. Nourshargh S, HordijkPL, Sixt M. 2010. Breachingmultiple barriers: leukocytemotility through venular walls and the interstitium. Nat. Rev. Mol. Cell Biol. 11:366-78
62. von Andrian UH, Mempel TR. 2003. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3:867-78
63. Miyasaka M, Tanaka T. 2004. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat. Rev. Immunol. 4:360-70
64. Warnock RA, Askari S, Butcher EC, von Andrian UH. 1998. Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J. Exp. Med. 187:205-16
65. Campbell JJ, Bowman EP, Murphy K, Youngman KR, Siani MA, et al. 1998. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3β receptor CCR7. J. Cell Biol. 141:1053-59
66. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT. 1998. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. PNAS 95:258-63
67. Stein JV, Rot A, Luo Y, Narasimhaswamy M, Nakano H, et al. 2000. The CC chemokine thymusderived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J. Exp. Med. 191:61-76
68. Baekkevold ES, Yamanaka T, Palframan RT, Carlsen HS, Reinholt FP, et al. 2001. The CCR7 ligand ELC (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J. Exp. Med. 193:1105-12
69. Pachynski RK, Wu SW, GunnMD, Erle DJ. 1998. Secondary lymphoid-tissue chemokine (SLC) stimulates integrin α4β7-mediated adhesion of lymphocytes to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) under flow. J. Immunol. 161:952-56
70. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, et al. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23-33
71. Warnock RA, Campbell JJ, Dorf ME, Matsuzawa A, McEvoy LM, Butcher EC. 2000. The role of chemokines in themicroenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules. J. Exp. Med. 191:77-88
72. Luther SA, TangHL, Hyman PL, Farr AG, Cyster JG. 2000. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. PNAS 97:12694-99
73. Okada T, Ngo VN, Ekland EH, Forster R, Lipp M, et al. 2002. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J. Exp. Med. 196:65-75
74. Bai Z, Hayasaka H, Kobayashi M, Li W, Guo Z, et al. 2009. CXC chemokine ligand 12 promotes CCR7-dependent naive T cell trafficking to lymph nodes and Peyer's patches. J. Immunol. 182:1287-95
75. Ebisuno Y, Tanaka T, Kanemitsu N, Kanda H, Yamaguchi K, et al. 2003. Cutting edge: The B cell chemokineCXCchemokine ligand 13/B lymphocyte chemoattractant is expressed in the high endothelial venules of lymph nodes and Peyer's patches and affects B cell trafficking across high endothelial venules. J. Immunol. 171:1642-46
76. Kanemitsu N, Ebisuno Y, Tanaka T, Otani K, Hayasaka H, et al. 2005. CXCL13 is an arrest chemokine for B cells in high endothelial venules. Blood 106:2613-18
77. Bromley SK, Mempel TR, Luster AD. 2008. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol. 9:970-80
78. Scimone ML, Felbinger TW, Mazo IB, Stein JV, von Andrian UH, Weninger W. 2004. CXCL12 mediates CCR7-independent homing of central memory cells, but not naive T cells, in peripheral lymph nodes. J. Exp. Med. 199:1113-20
79. Phillips R, Ager A. 2002. Activation of pertussis toxin-sensitive CXCL12 (SDF-1) receptors mediates transendothelial migration of T lymphocytes across lymph node high endothelial cells. Eur. J. Immunol. 32:837-47
80. Knowlden S, Georas SN. 2014. The autotaxin-LPA axis emerges as a novel regulator of lymphocyte homing and inflammation. J. Immunol. 192:851-57
81. Bai Z, Cai L, Umemoto E, Takeda A, Tohya K, et al. 2013. Constitutive lymphocyte transmigration across the basal lamina of high endothelial venules is regulated by the autotaxin/lysophosphatidic acid axis. J. Immunol. 190:2036-48
82. Lee M, Kiefel H, LaJevic MD, Macauley MS, Kawashima H, et al. 2014. Transcriptional programs of lymphoid tissue capillary and high endothelium reveal control mechanisms for lymphocyte homing. Nat. Immunol. 15:982-95
83. Yang BG, Tanaka T, JangMH, Bai Z,HayasakaH,MiyasakaM. 2007. Binding of lymphoid chemokines to collagen IV that accumulates in the basal lamina of high endothelial venules: its implications in lymphocyte trafficking. J. Immunol. 179:4376-82
84. Tsuboi K, Hirakawa J, Seki E, ImaiY,Yamaguchi Y, et al. 2013. Role of high endothelial venule-expressed heparan sulfate in chemokine presentation and lymphocyte homing. J. Immunol. 191:448-55
85. Nagakubo D, Murai T, Tanaka T, Usui T, Matsumoto M, et al. 2003. A high endothelial venule secretory protein, mac25/angiomodulin, interacts withmultiple high endothelial venule-associated molecules including chemokines. J. Immunol. 171:553-61
86. Carlsen HS, Haraldsen G, Brandtzaeg P, Baekkevold ES. 2005. Disparate lymphoid chemokine expression in mice and men: no evidence of CCL21 synthesis by human high endothelial venules. Blood 106:444-46
87. Shulman Z, Cohen SJ, Roediger B, Kalchenko V, Jain R, et al. 2012. Transendothelial migration of lymphocytes mediated by intraendothelial vesicle stores rather than by extracellular chemokine depots. Nat. Immunol. 13:67-76
88. Kashiwazaki M, Tanaka T, Kanda H, Ebisuno Y, Izawa D, et al. 2003. A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions. Int. Immunol. 15:1219-27
89. Comerford I, Nibbs RJ, Litchfield W, Bunting M, Harata-Lee Y, et al. 2010. The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses. Blood 116:4130-40
90. Gretz JE, Norbury CC, Anderson AO, Proudfoot AE, Shaw S. 2000. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocytemicroenvironments in lymph node cortex. J. Exp. Med. 192:1425-40
91. Palframan RT, Jung S, Cheng G,WeningerW, Luo Y, et al. 2001. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J. Exp. Med. 194:1361-73
92. Janatpour MJ, Hudak S, Sathe M, Sedgwick JD, McEvoy LM. 2001. Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment. J. Exp. Med. 194:1375-84
93. Gorlino CV, Ranocchia RP, HarmanMF, Garcia IA, Crespo MI, et al. 2014. Neutrophils exhibit differential requirements for homing molecules in their lymphatic and blood trafficking into draining lymph nodes. J. Immunol. 193:1966-74
94. Brackett CM, Muhitch JB, Evans SS, Gollnick SO. 2013. IL-17 promotes neutrophil entry into tumordraining lymph nodes following induction of sterile inflammation. J. Immunol. 191:4348-57
95. Cella M, JarrossayD, Facchetti F, Alebardi O, Nakajima H, et al. 1999. Plasmacytoid monocytesmigrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5:919-23
96. Seth S, Oberdorfer L,Hyde R,Hoff K, Thies V, et al. 2011. CCR7 essentially contributes to the homing of plasmacytoid dendritic cells to lymph nodes under steady-state as well as inflammatory conditions. J. Immunol. 186:3364-72
97. Matsutani T, Tanaka T, Tohya K, Otani K, Jang MH, et al. 2007. Plasmacytoid dendritic cells employ multiple cell adhesion molecules sequentially to interact with high endothelial venule cells-molecular basis of their trafficking to lymph nodes. Int. Immunol. 19:1031-37
98. Yoneyama H, Matsuno K, Zhang Y, Nishiwaki T, Kitabatake M, et al. 2004. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int. Immunol. 16:915-28
99. Mueller SN, Hosiawa-MeagherKA, Konieczny BT, Sullivan BM, Bachmann MF, et al. 2007. Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 317:670-74
100. Auffray C, Sieweke MH, Geissmann F. 2009. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27:669-92
101. Braun A,Worbs T, Moschovakis GL, Halle S, Hoffmann K, et al. 2011. Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration. Nat. Immunol. 12:879-87
102. Ulvmar MH,Werth K, Braun A, Kelay P, Hub E, et al. 2014. The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes. Nat. Immunol. 15:623-30
103. Abadie V, Badell E, Douillard P, Ensergueix D, Leenen PJ, et al. 2005. Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes. Blood 106:1843-50
104. Maletto BA, Ropolo AS, Alignani DO, LiscovskyMV, Ranocchia RP, et al. 2006. Presence of neutrophilbearing antigen in lymphoid organs of immune mice. Blood 108:3094-102
105. Chtanova T, Schaeffer M, Han SJ, van Dooren GG, Nollmann M, et al. 2008. Dynamics of neutrophil migration in lymph nodes during infection. Immunity 29:487-96
106. HamptonHR,Bailey J,TomuraM,Brink R, Chtanova T. 2015. Microbe-dependent lymphaticmigration of neutrophils modulates lymphocyte proliferation in lymph nodes. Nat. Commun. 6:7139
107. Beauvillain C, Cunin P, Doni A, Scotet M, Jaillon S, et al. 2010. CCR7 is involved in the migration of neutrophils to lymph nodes. Blood 117:1196-204
108. Bajenoff M, Egen JG, Koo LY, Laugier JP, Brau F, et al. 2006. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 25:989-1001
109. Park C, Hwang IY, Sinha RK, Kamenyeva O, Davis MD, Kehrl JH. 2012. Lymph node B lymphocyte trafficking is constrained by anatomy and highly dependent upon chemoattractant desensitization. Blood 119:978-89
110. Choe K, Hwang Y, SeoH, Kim P. 2013. In vivo high spatiotemporal resolution visualization of circulating T lymphocytes in high endothelial venules of lymph nodes. J. Biomed. Opt. 18:036005
111. Mempel TR, Junt T, von Andrian UH. 2006. Rulers over randomness: Stroma cells guide lymphocyte migration in lymph nodes. Immunity 25:867-69
112. Cahalan MD, Parker I. 2008. Choreography of cell motility and interaction dynamics imaged by twophoton microscopy in lymphoid organs. Annu. Rev. Immunol. 26:585-626
113. Bajenoff M, Granjeaud S, Guerder S. 2003. The strategy of T cell antigen-presenting cell encounter in antigen-draining lymph nodes revealed by imaging of initial T cell activation. J. Exp. Med. 198:715-24
114. Worbs T, Mempel TR, Bolter J, von Andrian UH, Forster R. 2007. CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivo. J. Exp. Med. 204:489-95
115. Asperti-Boursin F, Real E, Bismuth G, Trautmann A, Donnadieu E. 2007. CCR7 ligands control basal T cell motility within lymph node slices in a phosphoinositide 3-kinase-independent manner. J. Exp. Med. 204:1167-79
116. Coelho FM, Natale D, Soriano SF, Hons M, Swoger J, et al. 2013. Naive B-cell trafficking is shaped by local chemokine availability and LFA-1-independent stromal interactions. Blood 121:4101-9
117. Shi GX, Harrison K, Wilson GL, Moratz C, Kehrl JH. 2002. RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13. J. Immunol. 169:2507-15
118. Estes JD, Thacker TC,Hampton DL, Kell SA, Keele BF, et al. 2004. Follicular dendritic cell regulation of CXCR4-mediated germinal center CD4 T cell migration. J. Immunol. 173:6169-78
119. Moratz C, Hayman JR, Gu H, Kehrl JH. 2004. Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1-/-mice. Mol. Cell. Biol. 24:5767-75
120. Mempel TR, Henrickson SE, von Andrian UH. 2004. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427:154-59
121. Miller MJ, Safrina O, Parker I, Cahalan MD. 2004. Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. J. Exp. Med. 200:847-56
122. WoodruffMC, Heesters BA,Herndon CN,Groom JR, Thomas PG, et al. 2014. Trans-nodalmigration of resident dendritic cells into medullary interfollicular regions initiates immunity to influenza vaccine. J. Exp. Med. 211:1611-21
123. Ngo VN, Tang HL, Cyster JG. 1998. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J. Exp. Med. 188:181-91
124. Sallusto F, Palermo B, Lenig D, Miettinen M, Matikainen S, et al. 1999. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 29:1617-25
125. Friedman RS, Jacobelli J, KrummelMF. 2006. Surface-bound chemokines capture and prime T cells for synapse formation. Nat. Immunol. 7:1101-8
126. Zhao X, Sato A, Dela Cruz CS, Linehan M, Luegering A, et al. 2003. CCL9 is secreted by the follicleassociated epithelium and recruits dome region Peyer's patch CD11b+ dendritic cells. J. Immunol. 171:2797-803
127. Iwasaki A, Kelsall BL. 2000. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3α, MIP-3β, and secondary lymphoid organ chemokine. J. Exp. Med. 191:1381-94
128. Hase K, Murakami T, TakatsuH, ShimaokaT, IimuraM, et al. 2006. Themembrane-bound chemokine CXCL16 expressed on follicle-associated epithelium andMcells mediates lympho-epithelial interaction in GALT. J. Immunol. 176:43-51
129. Tang HL, Cyster JG. 1999. Chemokine up-regulation and activated T cell attraction by maturing dendritic cells. Science 284:819-22
130. Yoneyama H, Narumi S, Zhang Y, Murai M, Baggiolini M, et al. 2002. Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes. J. Exp. Med. 195:1257-66
131. Alferink J, Lieberam I, Reindl W, Behrens A, Weiss S, et al. 2003. Compartmentalized production of CCL17 in vivo: strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen. J. Exp. Med. 197:585-99
132. Leon B, Ballesteros-Tato A, Browning JL, Dunn R, Randall TD, Lund FE. 2012. Regulation of TH2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells. Nat. Immunol. 13:681-90
133. Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, Germain RN. 2006. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 440:890-95
134. Hugues S, Scholer A, Boissonnas A, Nussbaum A, Combadiere C, et al. 2007. Dynamic imaging of chemokine-dependent CD8+ T cell help for CD8+ T cell responses. Nat. Immunol. 8:921-30
135. Hickman HD, Li L, Reynoso GV, Rubin EJ, Skon CN, et al. 2011. Chemokines control naive CD8+ T cell selection of optimal lymph node antigen presenting cells. J. Exp. Med. 208:2511-24
136. KastenmullerW, Brandes M, Wang Z, Herz J, Egen JG, Germain RN. 2013. Peripheral prepositioning and local CXCL9 chemokine-mediated guidance orchestrate rapid memory CD8+ T cell responses in the lymph node. Immunity 38:502-13
137. Henry CJ, Ornelles DA, Mitchell LM, Brzoza-Lewis KL, Hiltbold EM. 2008. IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17. J. Immunol. 181:8576-84
138. Gerard A, Khan O, Beemiller P, Oswald E,HuJ, et al. 2013. SecondaryTcell-T cell synaptic interactions drive the differentiation of protective CD8+ T cells. Nat. Immunol. 14:356-63
139. Groom JR, Richmond J, Murooka TT, Sorensen EW, Sung JH, et al. 2012. CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation. Immunity 37:1091-103
140. Langenkamp A, Nagata K, Murphy K, Wu L, Lanzavecchia A, Sallusto F. 2003. Kinetics and expression patterns of chemokine receptors in human CD4+ T lymphocytes primed by myeloid or plasmacytoid dendritic cells. Eur. J. Immunol. 33:474-82
141. Kohlmeier JE, Reiley WW, Perona-Wright G, Freeman ML, Yager EJ, et al. 2011. Inflammatory chemokine receptors regulate CD8+ T cell contraction and memory generation following infection. J. Exp. Med. 208:1621-34
142. Castellino F, Germain RN. 2007. Chemokine-guided CD4+ T cell help enhances generation of IL-6RαhighIL-7Rαhigh prememory CD8+ T cells. J. Immunol. 178:778-87
143. Baekkevold ES,Wurbel MA, Kivisakk P,Wain CM, Power CA, et al. 2005. A role for CCR4 in development of mature circulating cutaneous T helper memory cell populations. J. Exp. Med. 201:1045-51
144. Sung JH, Zhang H, Moseman EA, Alvarez D, Iannacone M, et al. 2012. Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes. Cell 150:1249-63
145. Reif K, Ekland EH, Ohl L,NakanoH, LippM, et al. 2002. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 416:94-99
146. OkadaT,MillerMJ, Parker I, KrummelMF, NeighborsM, et al. 2005. Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLOS Biol. 3:e150
147. Ansel KM, McHeyzer-Williams LJ, Ngo VN, McHeyzer-Williams MG, Cyster JG. 1999. In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J. Exp. Med. 190:1123-34
148. Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, et al. 2000. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 192:1545-52
149. Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B. 2000. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192:1553-62
150. Kim CH,RottLS, Clark-Lewis I, Campbell DJ,WuL, ButcherEC. 2001. Subspecialization ofCXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells. J. Exp. Med. 193:1373-81
151. Allen CD, Okada T, Tang HL, Cyster JG. 2007. Imaging of germinal center selection events during affinity maturation. Science 315:528-31
152. Hauser AE, Junt T, Mempel TR, SneddonMW,Kleinstein SH, et al. 2007. Definition of germinal-center B cell migration in vivo reveals predominant intrazonal circulation patterns. Immunity 26:655-67
153. Schwickert TA, Lindquist RL, Shakhar G, Livshits G, Skokos D, et al. 2007. In vivo imaging of germinal centres reveals a dynamic open structure. Nature 446:83-87
154. Allen CD, Okada T, Cyster JG. 2007. Germinal-center organization and cellular dynamics. Immunity 27:190-202
155. Allen CD, Ansel KM, Low C, Lesley R, Tamamura H, et al. 2004. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat. Immunol. 5:943-52
156. Wang X, Cho B, Suzuki K, Xu Y, Green JA, et al. 2011. Follicular dendritic cells help establish follicle identity and promote B cell retention in germinal centers. J. Exp. Med. 208:2497-510
157. Lo CG, Xu Y, Proia RL, Cyster JG. 2005. Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit. J. Exp. Med. 201:291-301
158. Pham TH, Okada T, Matloubian M, Lo CG, Cyster JG. 2008. S1P1 receptor signaling overrides retention mediated by Gαi-coupled receptors to promote T cell egress. Immunity 28:122-33
159. Schmidt TH, Bannard O, Gray EE, Cyster JG. 2013. CXCR4 promotes B cell egress from Peyer's patches. J. Exp. Med. 210:1099-107
160. Schulz O, UgurM, FriedrichsenM, Radulovic K, Niess JH, et al. 2014. Hypertrophy of infected Peyer's patches arises from global, interferon-receptor, and CD69-independent shutdown of lymphocyte egress. Mucosal Immunol. 7:892-904
161. Shiow LR, Rosen DB, Brdickova N, Xu Y, An J, et al. 2006. CD69 acts downstream of interferonalpha/ beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440(7083):540-44
162. Schwab SR,Cyster JG. 2007. Finding a way out: lymphocyte egress from lymphoid organs. Nat. Immunol. 8(12):1295-301
163. Cyster JG, Schwab SR. 2012. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu. Rev. Immunol. 30:69-94
164. Kraal G, Schornagel K, Streeter PR,Holzmann B, Butcher EC. 1995. Expression of themucosal vascular addressin, MAdCAM-1, on sinus-lining cells in the spleen. Am. J. Pathol. 147:763-71
165. Katakai T, Suto H, SugaiM, Gonda H, Togawa A, et al. 2008. Organizer-like reticular stromal cell layer common to adult secondary lymphoid organs. J. Immunol. 181:6189-200
166. Lo CG, Lu TT, Cyster JG. 2003. Integrin-dependence of lymphocyte entry into the splenic white pulp. J. Exp. Med. 197:353-61
167. Steiniger B, Barth P, Hellinger A. 2001. The perifollicular and marginal zones of the human splenic white pulp: Do fibroblasts guide lymphocyte immigration? Am. J. Pathol. 159:501-12
168. Gatto D, Wood K, Brink R. 2011. EBI2 operates independently of but in cooperation with CXCR5 and CCR7 to direct B cell migration and organization in follicles and the germinal center. J. Immunol. 187:4621-28
169. Pereira JP, Kelly LM, Xu Y, Cyster JG. 2009. EBI2 mediates B cell segregation between the outer and centre follicle. Nature 460:1122-26
170. Nolte MA, Hamann A, Kraal G, Mebius RE. 2002. The strict regulation of lymphocyte migration to splenic white pulp does not involve common homing receptors. Immunology 106:299-307
171. Grayson MH, Hotchkiss RS, Karl IE, Holtzman MJ, Chaplin DD. 2003. Intravital microscopy comparing T lymphocyte trafficking to the spleen and the mesenteric lymph node. Am. J. Physiol. Heart Circ. Physiol. 284:H2213-26
172. Nolte MA, Belien JA, Schadee-Eestermans I, Jansen W, Unger WW, et al. 2003. A conduit system distributes chemokines and small blood-borne molecules through the splenic white pulp. J. Exp. Med. 198:505-12
173. Bajenoff M, Glaichenhaus N, Germain RN. 2008. Fibroblastic reticular cells guide T lymphocyte entry into and migration within the splenic T cell zone. J. Immunol. 181:3947-54
174. Umemoto E, Otani K, Ikeno T, Verjan Garcia N, Hayasaka H, et al. 2012. Constitutive plasmacytoid dendritic cell migration to the splenic white pulp is cooperatively regulated by CCR7-and CXCR4-mediated signaling. J. Immunol. 189:191-99
175. Yi T, Wang X, Kelly LM, An J, Xu Y, et al. 2012. Oxysterol gradient generation by lymphoid stromal cells guides activated B cell movement during humoral responses. Immunity 37:535-48
176. Liu C, Yang XV, Wu J, Kuei C, Mani NS, et al. 2011. Oxysterols direct B-cell migration through EBI2. Nature 475:519-23
177. Hannedouche S, Zhang J, YiT, ShenW,Nguyen D, et al. 2011. Oxysterols direct immune cell migration via EBI2. Nature 475:524-27
178. Ngo VN, Korner H, Gunn MD, Schmidt KN, Riminton DS, et al. 1999. Lymphotoxin α/βand tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med. 189:403-12
179. Matsumoto M, Mariathasan S, Nahm MH, Baranyay F, Peschon JJ, Chaplin DD. 1996. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science 271:1289-91
180. Mebius RE, van Tuijl S,Weissman IL, Randall TD. 1998. Transfer of primitive stem/progenitor bone marrow cells from LTα-/-donors to wild-type hosts: implications for the generation of architectural events in lymphoid B cell domains. J. Immunol. 161:3836-43
181. Endres R, Alimzhanov MB, Plitz T, Futterer A, Kosco-Vilbois MH, et al. 1999. Mature follicular dendritic cell networks depend on expression of lymphotoxin βreceptor by radioresistant stromal cells and of lymphotoxin βand tumor necrosis factor by B cells. J. Exp. Med. 189:159-68
182. Ngo VN, Cornall RJ, Cyster JG. 2001. Splenic T zone development is B cell dependent. J. Exp. Med. 194:1649-60
183. Zhao L, Liu L, Gao J, Yang Y, Hu C, et al. 2014. T lymphocytes maintain structure and function of fibroblastic reticular cells via lymphotoxin (LT)-B. BMC Immunol. 15:33
184. Lu TT, Cyster JG. 2002. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 297:409-12
185. Cinamon G, Zachariah MA, Lam OM, Foss FW Jr, Cyster JG. 2008. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat. Immunol. 9:54-62
186. Arnon TI, Horton RM, Grigorova IL, Cyster JG. 2013. Visualization of splenic marginal zone B-cell shuttling and follicular B-cell egress. Nature 493:684-88
187. Cinamon G, Matloubian M, Lesneski MJ, Xu Y, Low C, et al. 2004. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat. Immunol. 5:713-20
188. Vora KA, Nichols E, Porter G, Cui Y, Keohane CA, et al. 2005. Sphingosine 1-phosphate receptor agonist FTY720-phosphate causes marginal zone B cell displacement. J. Leukoc. Biol. 78:471-80
189. Wang H, Beaty N, Chen S, Qi CF, Masiuk M, et al. 2012. The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12. Blood 119:465-68
190. Luker KE, Steele JM, Mihalko LA, Ray P, Luker GD. 2010. Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands. Oncogene 29:4599-610
191. Aoshi T, Zinselmeyer BH, Konjufca V, Lynch JN, Zhang X, et al. 2008. Bacterial entry to the splenic white pulp initiates antigen presentation to CD8+ T cells. Immunity 29:476-86
192. Czeloth N, Schippers A, Wagner N, MullerW, Kuster B, et al. 2007. Sphingosine-1 phosphate signaling regulates positioning of dendritic cells within the spleen. J. Immunol. 179:5855-63
193. Rathinasamy A, Czeloth N, PabstO, Forster R, BernhardtG. 2010. The origin and maturity of dendritic cells determine the pattern of sphingosine 1-phosphate receptors expressed and required for efficient migration. J. Immunol. 185:4072-81
194. Vremec D, Pooley J, Hochrein H, Wu L, Shortman K. 2000. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164:2978-86
195. Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz VR, Trumpfheller C, et al. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science 315:107-11
196. Gatto D, Wood K, Caminschi I, Murphy-DurlandD, Schofield P, et al. 2013. The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells. Nat. Immunol. 14:446-53
197. Yi T, Cyster JG. 2013. EBI2-mediated bridging channel positioning supports splenic dendritic cell homeostasis and particulate antigen capture. eLife 2:e00757
198. Pooley JL, Heath WR, Shortman K. 2001. Cutting edge: Intravenous soluble antigen is presented to CD4 T cells by CD8-dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J. Immunol. 166:5327-30
199. Chappell CP,Draves KE,Giltiay NV, Clark EA. 2012. Extrafollicular B cell activation bymarginal zone dendritic cells drives T cell-dependent antibody responses. J. Exp. Med. 209:1825-40
200. Yu P, Wang Y, Chin RK,Martinez-Pomares L, Gordon S, et al. 2002. B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion. J. Immunol. 168:5117-23
201. Balazs M, Martin F, Zhou T, Kearney J. 2002. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17:341-52
202. Pape KA, Kouskoff V, Nemazee D, Tang HL, Cyster JG, et al. 2003. Visualization of the genesis and fate of isotype-switched B cells during a primary immune response. J. Exp. Med. 197:1677-87
203. Gatto D, Paus D, Basten A, Mackay CR, Brink R. 2009. Guidance of B cells by the orphan G protein-coupled receptor EBI2 shapes humoral immune responses. Immunity 31:259-69
204. Kurachi M, Kurachi J, Suenaga F, Tsukui T, Abe J, et al. 2011. Chemokine receptor CXCR3 facilitates CD8+ T cell differentiation into short-lived effector cells leading to memory degeneration. J. Exp.Med. 208:1605-20
205. Hu JK, Kagari T, Clingan JM, Matloubian M. 2011. Expression of chemokine receptor CXCR3 on T cells affects the balance between effector and memory CD8 T-cell generation. PNAS 108:E118-27
206. Ato M, Stager S, Engwerda CR, Kaye PM. 2002. Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat. Immunol. 3:1185-91
207. Scandella E, Bolinger B, Lattmann E, Miller S, Favre S, et al. 2008. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat. Immunol. 9:667-75
208. Khanna KM,McNamara JT, Lefrancois L. 2007. In situ imaging of the endogenous CD8Tcell response to infection. Science 318:116-20
209. Shimizu K, Morikawa S, Kitahara S, Ezaki T. 2009. Local lymphogenic migration pathway in normal mouse spleen. Cell Tissue Res. 338:423-32
210. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, et al. 2004. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427:355-60
211. Sze DM, Toellner KM, Garcia de Vinuesa C, Taylor DR,MacLennan IC. 2000. Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J. Exp. Med. 192:813-21
212. Ellyard JI, Avery DT, Mackay CR, Tangye SG. 2005. Contribution of stromal cells to the migration, function and retention of plasma cells in human spleen: potential roles of CXCL12, IL-6 and CD54. Eur. J. Immunol. 35:699-708
213. Hargreaves DC,Hyman PL, Lu TT, Ngo VN, Bidgol A, et al. 2001. A coordinated change in chemokine responsiveness guides plasma cell movements. J. Exp. Med. 194:45-56
214. Kabashima K, Haynes NM, Xu Y, Nutt SL, Allende ML, et al. 2006. Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism. J. Exp. Med. 203: 2683-90
215. Unsoeld H, Voehringer D, Krautwald S, Pircher H. 2004. Constitutive expression of CCR7 directs effector CD8 T cells into the splenic white pulp and impairs functional activity. J. Immunol. 173:3013-19
216. Schenkel JM, Fraser KA, Masopust D. 2014. Cutting edge: Resident memory CD8 T cells occupy frontline niches in secondary lymphoid organs. J. Immunol. 192:2961-64
217. Bajenoff M, Narni-Mancinelli E, Brau F, Lauvau G. 2010. Visualizing early splenic memory CD8+ T cells reactivation against intracellular bacteria in the mouse. PLOS ONE 5:e11524
218. Fleige H, Ravens S, Moschovakis GL, Bolter J, Willenzon S, et al. 2014. IL-17-induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs. J. Exp. Med. 211:643-51
219. Neyt K, Perros F, GeurtsvanKessel CH, Hammad H, Lambrecht BN. 2012. Tertiary lymphoid organs in infection and autoimmunity. Trends Immunol. 33:297-305
220. Aloisi F, Pujol-Borrell R. 2006. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 6:205-17
221. Drayton DL, Liao S, Mounzer RH, Ruddle NH. 2006. Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol. 7:344-53
222. Marinkovic T, Garin A, Yokota Y, Fu YX, Ruddle NH, et al. 2006. Interaction ofmature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. J. Clin. Investig. 116:2622-32
223. Rangel-Moreno J, Moyron-Quiroz JE, Hartson L, Kusser K, Randall TD. 2007. Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza. PNAS 104:10577-82
224. Luther SA, Bidgol A, Hargreaves DC, Schmidt A, Xu Y, et al. 2002. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 169:424-33
225. Rangel-Moreno J, Carragher DM, Luz Garcia-Hernandez M, Hwang JY, Kusser K, et al. 2011. The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat. Immunol. 12:639-46
226. Peters A, Pitcher LA, Sullivan JM, Mitsdoerffer M, Acton SE, et al. 2011. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 35:986-96
227. GeurtsvanKessel CH, Willart MA, Bergen IM, van Rijt LS, Muskens F, et al. 2009. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J. Exp. Med. 206:2339-49
228. Halle S, Dujardin HC, Bakocevic N, Fleige H, Danzer H, et al. 2009. Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells. J. Exp. Med. 206:2593-601
229. Muniz LR, Pacer ME, Lira SA, Furtado GC. 2011. A critical role for dendritic cells in the formation of lymphatic vessels within tertiary lymphoid structures. J. Immunol. 187:828-34
230. Kocks JR, Davalos-Misslitz AC, Hintzen G, Ohl L, Forster R. 2007. Regulatory T cells interfere with the development of bronchus-associated lymphoid tissue. J. Exp. Med. 204:723-34
231. Winter S, Loddenkemper C, Aebischer A, Rabel K, Hoffmann K, et al. 2010. The chemokine receptor CXCR5is pivotal for ectopicmucosa-associated lymphoid tissue neogenesis in chronic Helicobacter pylori-induced inflammation. J. Mol. Med. 88:1169-80
232. Wengner AM, Hopken UE, Petrow PK, Hartmann S, Schurigt U, et al. 2007. CXCR5-and CCR7-dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis. Arthritis Rheum. 56:3271-83
233. Barone F, Bombardieri M, Manzo A, Blades MC, Morgan PR, et al. 2005. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sj ogren's syndrome. Arthritis Rheum. 52:1773-84
234. Shiao YM, Lee CC, Hsu YH, Huang SF, Lin CY, et al. 2010. Ectopic and high CXCL13 chemokine expression in myasthenia gravis with thymic lymphoid hyperplasia. J. Neuroimmunol. 221:101-6
235. Schmutz C,Hulme A, Burman A, Salmon M, Ashton B, et al. 2005. Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5. Arthritis Res. Ther. 7:R217-29
236. Takemura S, Braun A, Crowson C, Kurtin PJ, Cofield RH, et al. 2001. Lymphoid neogenesis in rheumatoid synovitis. J. Immunol. 167:1072-80
237. Carlsen HS, Baekkevold ES,MortonHC, Haraldsen G, Brandtzaeg P. 2004. Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood 104:3021-27
238. Buckley CD, AmftN, Bradfield PF, Pilling D, Ross E, et al. 2000. Persistent induction of the chemokine receptorCXCR4byTGF-β1 on synovialTcells contributes to their accumulationwithin the rheumatoid synovium. J. Immunol. 165:3423-29
239. Finch DK, Ettinger R, Karnell JL, Herbst R, Sleeman MA. 2013. Effects of CXCL13 inhibition on lymphoid follicles in models of autoimmune disease. Eur. J. Clin. Investig. 43:501-9
240. Zheng B, Ozen Z, Zhang X, De Silva S, Marinova E, et al. 2005. CXCL13 neutralization reduces the severity of collagen-induced arthritis. Arthritis Rheum. 52:620-26
241. Kramer JM, Klimatcheva E, Rothstein TL. 2013. CXCL13 is elevated in Sj ogren's syndrome in mice and humans and is implicated in disease pathogenesis. J. Leukoc. Biol. 94:1079-89
242. Bagaeva LV, Rao P, Powers JM, Segal BM. 2006. CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis. J. Immunol. 176:7676-85
243. Horuk R. 2009. Chemokine receptor antagonists: overcoming developmental hurdles. Nat. Rev. Drug Discov. 8:23-33
244. Pease J, Horuk R. 2012. Chemokine receptor antagonists. J. Med. Chem. 55:9363-92
245. Cyster JG. 1999. Chemokines and cell migration in secondary lymphoid organs. Science 286:2098-102
246. Steiniger BS. 2015. Human spleen microanatomy: why mice do not suffice. Immunology 145:334-46